Ulrik B Nielsen - Director, Merrimack Pharmaceuticals Inc

As of June 7, 2022


What is Ulrik B Nielsen's Net Worth?

The current estimated net worth of Merrimack Pharmaceuticals Inc's Director, Ulrik B Nielsen, is estimated to be about $4.66M . Ulrik B Nielsen owns about 36,968 units of Merrimack Pharmaceuticals Inc common stock. In the last 10 years at Merrimack Pharmaceuticals Inc, Ulrik B Nielsen has sold an estimated value of $0 worth.

What is Ulrik B Nielsen's Past Insider Trading?

Ulrik B Nielsen's largest purchase order was 14,287 units , worth over $60.63K on January 25, 2022. In total, Ulrik B Nielsen has made about 6 transactions over 10 years of their time at Merrimack Pharmaceuticals Inc. Ulrik B Nielsen usually trades in June, with the busiest year in 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Ulrik B Nielsen's' Mailing Address?

  • Mailing address is Merrimack Pharmaceuticals, Inc. One Kendall Square, Suite B7201 Cambridge MA 02139 MA

Merrimack Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Gary L. Crocker 2019 $76,000 $ $19,258 $ $ $95,258
Richard Peters 2019 $383,676 $294,891 $ $ $935,369 $1,613,936
Jean M. Franchi 2019 $214,087 $77,544 $ $ $524,461 $816,092
Jeffrey A. Munsie 2019 $209,658 $72,015 $ $ $478,659 $760,332
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1274792/000119312521126831/d97305ddef14a.htm

What are Merrimack Pharmaceuticals Inc's Past Insider Trades?

Merrimack Pharmaceuticals Inc's most recent insider trade came on June 27, 2022 by Noah Levy, Newtyn Management Llc, Newtyn Partners Lp, Newtyn Te Partners Lp, Newtyn Capital Partners Lp and Ledo Capital Llc who bought 1,500 units worth $8.99K . In the last 10 years, insiders at Merrimack Pharmaceuticals Inc have sold an estimated value of $15.57M and bought an estimated value of $20.76M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Gary L Crocker, See Remarks,  Michael Porter, Director,  and Edward Stewart, Head Commercial .

MERRIMACK PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1